World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
11657
World Ranking
4576
National Ranking
199

Ian James publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ian James sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 210 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ian James D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ian James sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ian James is affiliated with the Perron Institute for Neurological and Translational Science in Australia. Their research spans multiple fields, primarily focusing on medicine and agricultural and biological sciences.

Their work covers key subfields such as insect science, neurology, genetics, infectious diseases, and immunology. Ian James has contributed to topics including amyotrophic lateral sclerosis research, neurogenetic and muscular disorders research, insect symbiosis and bacterial influences, SARS-CoV-2 and COVID-19 research, viral gastroenteritis research and epidemiology, immunodeficiency and autoimmune disorders, and Parkinson's disease mechanisms and treatments.

Ian James has published in several venues, frequently appearing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neurology Genetics
  • Pathogens and Immunity
  • Frontiers in Aging Neuroscience
  • Current Biology

Their recent papers include:

  • Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA Level, 2021, Pathogens and Immunity
  • Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype, 2021, Frontiers in Aging Neuroscience
  • Generation of a novel SARS-CoV-2 sub-genomic RNA due to the R203K/G204R variant in nucleocapsid: homologous recombination has potential to change SARS-CoV-2 at both protein and RNA level, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Rational engineering of a synthetic insect-bacterial mutualism, 2022, Current Biology
  • New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals, 2020, Human Immunology

Ian James frequently collaborates with colleagues in their research, including:

  • Frank Mastaglia
  • Colin Dale
  • Abha Chopra
  • S. Mallal
  • Frances Theunissen

In addition to journal publications, Ian James has contributed to book publishing, with a forthcoming title titled Rethinking Literary Naturalism scheduled for 2025 with Liverpool University Press.

Best Publications

  • Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

    S. Mallal;S. Mallal;D. Nolan;C. Witt;C. Witt;G. Masel;G. Masel

  • Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

    Photini Kiepiela;Alasdair J. Leslie;Isobella Honeyborne;Danni Ramduth

  • Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level

    Corey B. Moore;Mina John;Ian R. James;Frank T. Christiansen;Frank T. Christiansen

  • Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.

    Simon A Mallal;Mina John;Corey B. Moore;Ian R. James

  • Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant

    Annalise M. Martin;David Nolan;Silvana Gaudieri;Silvana Gaudieri;Coral Ann Almeida

  • Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy

    M.A. French;N. Lenzo;M. John;S.A. Mallal

  • Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts

    Annalise M Martin;David Nolan;Ian James;Paul Cameron

  • Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

    Mina John;Corey B. Moore;Ian R. James;David Nolan

  • Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580

    James G. Conway;Brad McDonald;Janet Parham;Barry Keith

  • Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir

    David Nolan;Richard Upton;Elizabeth McKinnon;Mina John

  • Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation

    Craig Pace;Jean Keller;David Nolan;Ian James

  • Improving the Effectiveness of Penicillin Allergy De-labeling.

    Jack Bourke;Jack Bourke;Rebecca Pavlos;Ian James;Elizabeth Phillips

  • Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level.

    David Nolan;Emma Hammond;Ian James;Elizabeth McKinnon

  • HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms.

    Katherine C. Konvinse;Jason A. Trubiano;Jason A. Trubiano;Rebecca Pavlos;Ian James

  • Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype

    Alexandre Harari;Cristina Cellerai;Felicitas Bellutti Enders;Josef Köstler

  • Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy.

    Silvana Gaudieri;Andri Rauch;Andri Rauch;Katja Pfafferott;Eleanor Barnes

  • Population-based V3 Genotypic Tropism Assay: A Retrospective Analysis Using Screening Samples From the A4001029 and MOTIVATE Studies

    Rachel A McGovern;Alexander Thielen;Theresa Mo;Winnie Dong

  • Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing.

    John Archer;Michael S Braverman;Bruce E Taillon;Brian Desany

  • Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patients.

    Mina John;Elizabeth J. Mckinnon;Ian R. James;David A. Nolan

  • Evidence of Viral Adaptation to HLA Class I-Restricted Immune Pressure in Chronic Hepatitis C Virus Infection

    Silvana Gaudieri;Andri Rauch;Lawrence P. Park;Elizabeth Freitas

  • Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.

    Andrew Lim;Dino Tan;Patricia Price;Adeeba Kamarulzaman

  • Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis

    D.B.A. Tan;Y.K. Yong;H.Y. Tan;A. Kamarulzaman

  • Divergent Adaptation of Hepatitis C Virus Genotypes 1 and 3 to Human Leukocyte Antigen-Restricted Immune Pressure

    Andri Rauch;Ian James;Katja Pfafferott;David Nolan

Frequent Co-Authors

Simon Mallal
Simon Mallal Vanderbilt University Medical Center
David Nolan
David Nolan Royal Perth Hospital
Mina John
Mina John Royal Perth Hospital
Silvana Gaudieri
Silvana Gaudieri University of Western Australia
Frank T. Christiansen
Frank T. Christiansen University of Western Australia
Frank L. Mastaglia
Frank L. Mastaglia University of Western Australia
Andri Rauch
Andri Rauch University of Bern
Elizabeth J. Phillips
Elizabeth J. Phillips Vanderbilt University Medical Center
Martyn A. French
Martyn A. French University of Western Australia
Hansjakob Furrer
Hansjakob Furrer University of Bern

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare degrees can open diverse career pathways. Many students explore advanced nursing roles like becoming a Nurse Practitioner, where programs vary in intensity and format. Finding the easiest online nurse practitioner programs can make the journey more manageable, especially for working professionals seeking flexible study options.

Mental health is a growing specialization within healthcare, and becoming a Psychiatric Mental Health Nurse Practitioner (PMHNP) is a popular route. Prospective students should consider programs with strong clinical experiences by reviewing the best online psychiatric mental health nurse practitioner programs.

Cost is another critical factor. Many care providers benefit from affordable education, so exploring the cheapest pmhnp certificate programs can help minimize student debt while still achieving career goals.

After obtaining advanced degrees, salary expectations vary by state and specialization. For example, the earnings of Doctors of Nursing Practice (DNPs) reflect this variability, making it important to research regional trends such as those found in details about how much do dnps make.

Best Scientists Citing Ian James

Trending Scientists

Recently Published Articles